Brief: Guard Therapeutics Receives Patent Approval For RMC-035 In China

Disruptive Pharma AB (publ)

09/01/2023 14:06

Jan 9 (Reuters) - Guard Therapeutics International AB
(publ)  GUARD.ST :
    * RECEIVES PATENT APPROVAL FOR RMC-035 IN CHINA
    * APPROVED PATENT IS OFFICIALLY ANNOUNCED AS PATENT NO. CN
108779157 B AND WILL BE VALID UNTIL 2037

Source text for Eikon:  ID:nMFN1cwJhV 
Further company coverage:  GUARD.ST 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))